Elevai Labs, Inc (NASDAQ:ELAB) IPO will take place November, 14 on the NASDAQ exchange under the ticker ELAB.
The company is offering shares at an expected price between $4.00 and $6.00 per share with an insider lock-up period of 180 days ending on May 12, 2024.
See also: Benzinga IPO Calendar
About Elevai Labs, Inc
levai Labs, Inc is a physician-dispensed skincare company with a focus on modernizing aesthetic skincare
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.